Secondary prevention of coronary heart disease is less agressive in patients over 64 years

Miguel A. Muñoz, Jaume Marrugat, Enriqueta Pujol, Enric Hernández, Maria Antonia Llauger, Cristina Contijoch, Oriol Armengol, Martí Birules, Jaume Escoda, Vicens Gonzalez, Eduard Carrión, Ignasi Pla, Jordi Admetlla, Josefa Coll, M. José Figuera, Enric Garrell, Ana M. Pérez, Juan Manuel Robles, Francesca Zapater, Enric CoronaJoana Ruiz, Francesc Anguera, Jordi Puig, Silvia Reig, Joana Ruiz, Enric Cepero, Josep Espinasa, Salvador Bertrán, Jordi Cebrià, Francisco Ortega, Jordi Sobrequés, Josep M. Viaplana, Alicia Val, Carmen Barrio, Carmen Tamayo, Ana Rosa Hernández, Ana Espinola, Eugenia Corral, Ramón Creus, Silvia Saura, Emili Marco, Jordi Taberner, Lluís Vicens, Marta Verdaguer, Begoña Santana, Anna Carme Jordana, Manel Prat, Adriana Planas, Judit Dalmau, Marta Martí, Elia Gavilan, Yolanda Romero, Ana de la Arada, Anna de Moner, Carmen Contreras, Rosa Mar de Miguel, Anna Gasol, Carmen Cabezas, Sagrario Alia, Jordi Vilaseca, M. Ángeles Mendez, Pilar Garces, Leopoldo Sandé, Gabriel Pou, Candy Lafuente, Ana Lafuente, M. del Mar Domingo, Núria Montellà, Montserrat Freixas, Judir Llussà, Silvia Zamora, Eulàlia Borrell, Xavier Mezquiriz, Xavier Joaquinet, Joan Vila, Pere Martínez, Jordi Forcada, Ana Altaba, Ernest Vinyoles, Josep Davins, Silvia Calvet, Clara Pareja, Juantxo Mendive, Mariano De la Figuera, Carmen Espel, Manel Mata, Ramón Ciurana, Carlos De Juan, Alberto Ramos, Sebastian Calero, Josep Sanz, Víctor Barriel, Andrés Cano, Montserrat Baré, Jordi Vilà, Eva Tarrats, Magda Pedrosa, Carmen Berbel, Juan A. García

Research output: Contribution to journalArticleResearchpeer-review

14 Citations (Scopus)

Abstract

Introduction and objectives. Although elderly people has a higher incidence of coronary heart disease, this group is seldom included in clinical trials. Studies performed in Spain on elderly coronary heart disease patients have been conducted in hospital settings. The aim of our study was to analyse wether the management of coronary heart disease patients over 64 years of age cared by family physicians differed from that of the rest. Patients and method. Cross-sectional multicentre study embedded in a clinical trial on 1,022 patients with stable coronary heart disease in which socio-demographic variables, comorbidity, treatment and cardiovascular risk- factor control were collected. Results. Mean age was 64 ± 10, 74.0% were men and 53.8% of subjects were over 64 years. Patients over 64 years had a greater cardiovascular comorbidity (87.7 vs 82.6%; p = 0.002) and received lower number of drugs than the rest in the prevention of recurrences (60.4 vs 70.9%; p < 0.001). Probability to receive less than two drugs on secondary prevention by subjects over 64 years was 0.45 (95% CI, 0.30-0.68) despite comorbidity, sex and cardiovascular risk profile. Conclusions. Coronary heart disease patients over 64 years receive less drugs for coronary event recurrence prevention than their younger counterparts despite their worse cardiovascular risk profile.
Original languageEnglish
Pages (from-to)586-593
JournalRevista Espanola de Cardiologia
Volume56
Issue number6
DOIs
Publication statusPublished - 1 Jun 2003

Keywords

  • Aging
  • Coronary disease
  • Prevention

Fingerprint Dive into the research topics of 'Secondary prevention of coronary heart disease is less agressive in patients over 64 years'. Together they form a unique fingerprint.

Cite this